Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

被引:1
|
作者
Khan, Sana Irfan
Anwar, Muhammad Yasir
Rafae, Abdul
Khan, Anam
Khan, Atif Irfan
Aamir, Sobia
Batool, Syeda Sabeeka
Din, Asim Tameez Ud
Khan, Israr
Javaid, Anum
Qadeer, Haifza Abeera
Ahmed, Zahoor
Gul, Rohail
Aijaz, Zobia
Anwer, Faiz
机构
关键词
D O I
10.1182/blood-2020-134986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma
    Rodgers, Thomas D.
    Williams, AnnaLynn M.
    Baran, Andrea
    Reagan, Patrick M.
    Casulo, Carla
    Zent, Clive S.
    Evans, Andrew
    Friedberg, Jonathan W.
    Barr, Paul M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 598 - 605
  • [42] Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models
    Spoerke, Jill M.
    O'Brien, Carol
    Huw, Ling
    Koeppen, Hartmut
    Fridlyand, Jane
    Brachmann, Rainer K.
    Haverty, Peter M.
    Pandita, Ajay
    Mohan, Sankar
    Sampath, Deepak
    Friedman, Lori S.
    Ross, Leanne
    Hampton, Garret M.
    Amler, Lukas C.
    Shames, David S.
    Lackner, Mark R.
    CLINICAL CANCER RESEARCH, 2012, 18 (24) : 6771 - 6783
  • [43] Kinase activity of phosphoinositide 3-kinase gamma (PI3Kγ) is important for neutrophil infiltration in inflammation
    Sablad, Marciano
    Castro, Glenda
    Rozenkrants, Natasha
    Ngo, Karen
    Rao, Tadimeti
    Zhang, Yan
    Fung-Leung, Wai-Ping
    FASEB JOURNAL, 2012, 26
  • [44] Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis
    Sharda, Esha
    Patel, Raahil S.
    Miguel Juarez-Salcedo, Luis
    Dalia, Samir
    Hanna, Catherine H.
    Gruhonjic, Hanan
    Ponnaganti, Bharat S.
    Mhaskar, Rahul
    LEUKEMIA RESEARCH, 2021, 108
  • [45] The Non-hodgkin Lymphoma Treatment and Side Effects: A Systematic Review and Meta-analysis
    Camara, Alice Barros
    Brandao, Igor Augusto
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024, 19 (01) : 93 - 120
  • [46] Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis
    Tramacere, I.
    Pelucchi, C.
    Bonifazi, M.
    Bagnardi, V.
    Rota, M.
    Bellocco, R.
    Scotti, L.
    Islami, F.
    Corrao, G.
    Boffetta, P.
    La Vecchia, C.
    Negri, E.
    ANNALS OF ONCOLOGY, 2012, 23 (11) : 2791 - 2798
  • [47] Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer A Systematic Review and Meta-analysis
    Jfri, Abdulhadi
    Meltzer, Rachel
    Mostaghimi, Arash
    LeBoeuf, Nicole
    Guggina, Lauren
    JAMA ONCOLOGY, 2022, 8 (11) : 1635 - 1643
  • [48] Binding and selectivity studies of phosphatidylinositol 3-kinase (PI3K) inhibitors
    Al Hasan, Mohammad
    Sabirianov, Matthew
    Redwine, Grace
    Goettsch, Kaitlin
    Yang, Stephen X.
    Zhong, Haizhen A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2023, 121
  • [49] Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailability
    Kawada, Hatsuo
    Ebiike, Hirosato
    Tsukazaki, Masao
    Yamamoto, Shun
    Koyama, Kohei
    Nakamura, Mitsuaki
    Morikami, Kenji
    Yoshinari, Kiyoshi
    Yoshida, Miyuki
    Ogawa, Kotaro
    Shinma, Nobuo
    Tsukuda, Takuo
    Ohwada, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) : 7650 - 7660
  • [50] Efficacy of Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Sultan, Anita
    Grant, Bradley J.
    Quick, Donald P.
    Graf, Chandler
    Swarup, Sriman
    Swarup, Sriman
    Kopel, Jonathan
    Htut, Thura Win
    Ball, Somedeb
    Phyu, Ei Moe
    Han, Myat Min
    Myat, Yin Mon
    D'Cunha, Nicholas
    Win, Myint Aung
    Thein, Kyaw Zin
    BLOOD, 2019, 134